HSBC Holdings’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8K | Sell |
13,703
-8,132
| -37% | -$8.17K | ﹤0.01% | 2514 |
|
|
2025
Q1 | $31.8K | Sell |
21,835
-144
| -0.7% | -$210 | ﹤0.01% | 2488 |
|
|
2024
Q4 | $48.2K | Sell |
21,979
-3,676
| -14% | -$8.07K | ﹤0.01% | 2557 |
|
|
2024
Q3 | $42.2K | Buy |
+25,655
| New | +$42.2K | ﹤0.01% | 2508 |
|
|
2023
Q1 | – | Sell |
-18,516
| Closed | -$115K | – | 2304 |
|
|
2022
Q4 | $115K | Hold |
18,516
| – | – | ﹤0.01% | 2402 |
|
|
2022
Q3 | $125K | Sell |
18,516
-210
| -1% | -$1.42K | ﹤0.01% | 2279 |
|
|
2022
Q2 | $118K | Sell |
18,726
-3,190
| -15% | -$20.1K | ﹤0.01% | 2577 |
|
|
2022
Q1 | $103K | Buy |
+21,916
| New | +$103K | ﹤0.01% | 2734 |
|
|
2021
Q2 | – | Sell |
-9,124
| Closed | -$256K | – | 2498 |
|
|
2021
Q1 | $256K | Sell |
9,124
-4,144
| -31% | -$116K | ﹤0.01% | 2046 |
|
|
2020
Q4 | $350K | Buy |
13,268
+3,894
| +42% | +$103K | ﹤0.01% | 2047 |
|
|
2020
Q3 | $352K | Sell |
9,374
-201,236
| -96% | -$7.56M | ﹤0.01% | 1747 |
|
|
2020
Q2 | $10.8M | Buy |
210,610
+7,979
| +4% | +$409K | 0.02% | 533 |
|
|
2020
Q1 | $6.46M | Buy |
202,631
+9,920
| +5% | +$316K | 0.02% | 607 |
|
|
2019
Q4 | $11.6M | Buy |
192,711
+162,711
| +542% | +$9.77M | 0.02% | 564 |
|
|
2019
Q3 | $1.1M | Sell |
30,000
-24,702
| -45% | -$906K | ﹤0.01% | 1358 |
|
|
2019
Q2 | $2.55M | Sell |
54,702
-68,632
| -56% | -$3.19M | ﹤0.01% | 997 |
|
|
2019
Q1 | $4.95M | Sell |
123,334
-117,256
| -49% | -$4.71M | 0.01% | 799 |
|
|
2018
Q4 | $11.1M | Buy |
+240,590
| New | +$11.1M | 0.02% | 542 |
|